These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27074215)

  • 1. [Molecular Pathological Aspects in Visceral Surgery].
    Unger T; Sändig I; Wittekind C
    Zentralbl Chir; 2016 Apr; 141(2):220-8. PubMed ID: 27074215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From nodule to differentiated thyroid carcinoma: contributions of molecular analysis in 2012.
    Albarel F; Conte-Devolx B; Oliver C
    Ann Endocrinol (Paris); 2012 Jun; 73(3):155-64. PubMed ID: 22503804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The surgical aspects of the digestive carcinoid tumor].
    García-Sancho Martín L
    An R Acad Nac Med (Madr); 1993; 110(1):145-97. PubMed ID: 8238818
    [No Abstract]   [Full Text] [Related]  

  • 4. [Predictive biomarkers for tumor-relevant signaling pathways in molecular pathology].
    Bonzheim I; Fend F
    Pathologe; 2014 Feb; 35(1):93-105. PubMed ID: 24496994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetic markers for thyroid FNAB. Established assays and future perspective.
    Musholt TJ; Musholt PB
    Nuklearmedizin; 2015; 54(3):94-100. PubMed ID: 26105717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
    Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
    Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathologic-anatomic diagnosis of endocrine neoplasms: new trends and applications].
    Kaserer K
    Wien Klin Wochenschr; 2003; 115 Suppl 2():6-9. PubMed ID: 15518139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuroendocrine tumours of the GI tract--data from the German NET Registry].
    Begum N; Maasberg S; Plöckinger U; Anlauf M; Rinke A; Pöpperl G; Lehnert H; Izbicki JR; Krausch M; Vashist YK; Raffel A; Bürk CG; Hoffmann J; Goretzki P; Pape UF;
    Zentralbl Chir; 2014 Jun; 139(3):276-83. PubMed ID: 23042103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
    Auernhammer CJ; Jauch KW; Hoffmann JN
    Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Molecular Pathology in Endocrine Pathology.
    Linke ES; Tezel GG
    Turk Patoloji Derg; 2015; 31 Suppl 1():181-8. PubMed ID: 26177327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.
    Paulson L; Shindo M; Schuff K; Corless C
    Arch Otolaryngol Head Neck Surg; 2012 Jan; 138(1):44-9. PubMed ID: 22249628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
    Mortensen MB
    Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopist's view of the future role of the gastroenterologist in digestive oncology.
    Tytgat GN
    J Dig Dis; 2013 Mar; 14(3):109-12. PubMed ID: 23167637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of molecular markers in follicular cell-derived thyroid cancer.
    Pinto AE; Leite V; Soares J
    Expert Rev Mol Diagn; 2009 Oct; 9(7):679-94. PubMed ID: 19817553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New technology in thyroid fine-needle aspiration.
    Poller DN
    J Clin Pathol; 2014 Jun; 67(6):457. PubMed ID: 24695840
    [No Abstract]   [Full Text] [Related]  

  • 16. Indeterminate Single Thyroid Nodule: Synergistic Impact of Mutational Markers and Sonographic Features in Triaging Patients to Appropriate Surgery.
    De Napoli L; Bakkar S; Ambrosini CE; Materazzi G; Proietti A; Macerola E; Basolo F; Miccoli P
    Thyroid; 2016 Mar; 26(3):390-4. PubMed ID: 26548748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular diagnostics--quo vadis?].
    Weichert W
    Pathologe; 2013 Nov; 34 Suppl 2():230-1. PubMed ID: 24196619
    [No Abstract]   [Full Text] [Related]  

  • 18. [Molecular diagnostics of non-small cell lung cancer: New markers and technologies].
    Warth A; Endris V; Kriegsmann M; Stenzinger A; Penzel R; Pfarr N; Weichert W
    Pathologe; 2015 Mar; 36(2):154-63. PubMed ID: 25820445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.
    Beaudenon-Huibregtse S; Alexander EK; Guttler RB; Hershman JM; Babu V; Blevins TC; Moore P; Andruss B; Labourier E
    Thyroid; 2014 Oct; 24(10):1479-87. PubMed ID: 24811481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating Molecular Testing in the Diagnosis and Management of Children with Thyroid Lesions.
    Ballester LY; Sarabia SF; Sayeed H; Patel N; Baalwa J; Athanassaki I; Hernandez JA; Fang E; Quintanilla NM; Roy A; López-Terrada DH
    Pediatr Dev Pathol; 2016; 19(2):94-100. PubMed ID: 26366474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.